Chronic Neuropathic Pain KOL Survey

Market: Pharma & Healthcare

Global, 8 pages report, published by Informa

Report ThumbnailMarch-2017
Biomedtracker  performed a 5-question survey of 30 United States neurologists who currently treat patients with chronic neuropathic pain and prescribe opioids to at least some of their patients with chronic neuropathic pain to gauge current use of adjuvants (TCAs, anti-convulsants, SNRIs, SSRIs, and NMDA receptor antagonists) and potential future use of cebranopadol and raxatrigine to treat chronic neuropathic pain.


Biomedtracker will be offering KOL Reports and Physician Pulse Surveys

Read More
  • Survey
Read More

Please select a license type


Related Products

InformaChronic Neuropathic Pain KOL SurveyProduct ThumbnailChronic Neuropathic Pain KOL Survey, Industry ReportProduct #: 770025
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2021 Global Market Analyst. All Rights Reserved